Menarini Group
Manufacturing · Italy · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Via Dei Sette Santi 1, Florence, Provinc...Phone Number
+39 5556801Website
www.menarini.comRevenue
$4.6 BillionIndustry
About Menarini Group
Menarini Group Org Chart
Is Menarini Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Menarini Group launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Menarini Group had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Menarini Group is spiking on competitors!
Earning: See what the market has to say on Menarini Group recently announced quarterly report
Menarini Group, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Menarini Group
Check if Menarini Group has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Menarini Group has new funding data
Recommended Actions
Find VP level buyers at Menarini Group
Find 3 more new buyers
Company Profile Activity
Activity Insights
Menarini Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Menarini Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Menarini Group.
Menarini Group Tech Stack
A closer look at the technologies used by Menarini Group
Most Recent Scoops
Menarini Group News & Media
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
FLORENCE, Italy and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, announced that new data related to ORSERDU® (elacestrant) and ELZONRIS® (tagraxofusp-erzs) will be presented at the 2026 American Society of Clinical Oncology (ASCO) AnMENARINI GROUP: THOMAS CUENI APPOINTED NEW MEMBER OF THE BOARD
FLORENCE, Italy, May 7, 2026 /PRNewswire/ -- The Menarini Group's Board of Directors has appointed the experienced executive Thomas Cueni as a new Director, further strengthening the Group's governance. Cueni joins Chairman Eric Cornut, CEO Elcin Barker Ergun, shareholders Lucia and...Medidata Expands Partnership with The Menarini Group, Deploying Medidata’s Study Build AI Technology to Accelerate Global Oncology Pipeline
Fourteen-year collaboration enters a new phase as Menarini evolves its use of the Medidata Platform, combining established clinical workflows with AI to power its global oncology pipeline Fourteen-year collaboration enters a new phase as Menarini evolves its use of the Medidata Platform, combining established clinical workflows with AI to power its global oncology pipelineMenarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
FLORENCE, Italy and NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, will present updated meaningful median progression-free survival (mPFS) efficacy results from two combination regimens of the Phase 2 ELEVATE study in patients with es
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Menarini Group
The Menarini Group is an Italian pharmaceutical company. The Menarini Group has always pursued two strategic objectives: Research and Internationalisation and is present in the most important therapeutic areas including products for cardiology, gastroenterology, pneumology/antibiotics, diabetology, anti-inflammatory agents/analgesics. The Menarini... Read More